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Ampliﬁcation of R-spondin1 signaling induces granulosa cell
fate defects and cancers in mouse adult ovary
M-C De Cian1,2,9, E Pauper1,9, R Bandiera3,9, VPI Vidal1, S Sacco1, EP Gregoire1, A-A Chassot1, C Panzolini1, D Wilhelm4, E Pailhoux5,
SA Youssef6, A de Bruin6,7, K Teerds8, A Schedl1, I Gillot1 and M-C Chaboissier1
R-spondin1 is a secreted regulator of WNT signaling, involved in both embryonic development and homeostasis of adult organs. It can
have a dual role, acting either as a mitogen or as a tumor suppressor. During ovarian development, Rspo1 is a key factor required for
sex determination and differentiation of the follicular cell progenitors, but is downregulated after birth. In human, increased RSPO1
expression is associated with ovarian carcinomas, but it is not clear whether it is a cause or a consequence of the tumorigenic process.
To address the role of Rspo1 expression in adult ovaries, we generated an Rspo1 gain-of-function mouse model. Females were
hypofertile and exhibited various ovarian defects, ranging from cysts to ovarian tumors. Detailed phenotypical characterization showed
anomalies in the ovulation process. Although follicles responded to initial follicle-stimulating hormone stimulation and developed
normally until the pre-ovulatory stage, they did not progress any further. Although non-ovulated oocytes degenerated, the
surrounding follicular cells did not begin atresia. RSPO1-induced expression not only promotes canonical WNT signaling but also alters
granulosa cell fate decisions by maintaining epithelial-like traits in these cells. This prevents follicle cells from undergoing apoptosis,
leading to the accumulation of granulosa cell tumors that reactivates the epithelial program from their progenitors. Taken together, our
data demonstrate that activation of RSPO1 is sufﬁcient in promoting ovarian tumors and thus supports a direct involvement of this
gene in the commencement of ovarian cancers.
Oncogene (2017) 36, 208–218; doi:10.1038/onc.2016.191; published online 6 June 2016
INTRODUCTION
WNT/β-catenin (CTNNB1) signaling is involved in numerous
biological processes from embryogenesis to stem cell activation.
Deregulation of this pathway is responsible for many diseases,
most notably colorectal cancer. Indeed, 90% of colorectal cancers
result from APC mutations leading to the activation of this
pathway.1 WNT signaling is tightly controlled by negative and
positive modulators like APC and R-spondins (RSPO), a family of
four members of secreted proteins. Fusions of RSPO2 and RSPO3
activate WNT signaling in colorectal cancers,2 and ampliﬁcations
of RSPO1 have been associated with 8% of ovarian epithelial
cancers.3,4 However, functional evidence for a direct involvement
of RSPO1 in ovarian tumor development is still missing.
Depending on the cell type, Rspo1 may act either as a mitogen
or a tumor suppressor:5,6 variants of the RSPO1 locus have been
reported in ovarian cancers highlighting its role as an oncogene.3,4 By
contrast, RSPO1 loss-of-function mutations predispose to squamous
cell carcinoma.6 On the molecular level, RSPO1 binds to the
recruitment receptors LGR4, LGR5 or LGR6 leading to stabilization
of CTNNB1, and in turn CTNNB1 interacts with transcription factors
such as LEF/TCF in the nucleus and trans-activates target genes
such as Axin2 (for a model, see ref. 7).
CTNNB1 is not only a key factor of the WNT signal-transduction
pathway, but is also a component of adherens junctions linking
cadherins via α-catenin to the actin cytoskeleton at the plasma
membrane of epithelial cells.8 The membrane function of CTNNB1
can be partially substituted by the related protein JUP (Plakoglobin/
γ-catenin), an important component of desmosomes that anchors
epithelial cells to intermediate ﬁlaments and can also act as
a signaling molecule at least in vitro.9,10 Several studies support a
role for JUP in cancer.11 Although a direct link between RSPO1 and
JUP has not yet been established, skin cells from patients affected
by RSPO1 loss-of-function mutations exhibit defects reminiscent
of desmosome abnormalities.6
In addition to the skin diseases, such as palmoplantar hyperker-
atosis, patients carrying mutations in RSPO1 exhibit female-to-male
sex reversal, and predisposition to squamous cell carcinoma and
seminoma.6,12 Using functional analysis in mice, the role of RSPO1
and canonical WNT signaling has been unraveled in female
ovarian development.13–15 Prior to sex determination, Rspo1 is
involved in the proliferation of progenitor cells that are located
within the surface epithelium of the undifferentiated gonads.16,17
Following sex determination, cells of the ovarian surface epithelium
(OSE) continue to proliferate and enter the gonads to give rise to
precursors of the granulosa cells.18,19 At this stage, Rspo1 is required
to maintain granulosa precursors in the undifferentiated state.14,20
Accordingly, LGR4- and LGR5-expressing precursor cells contribute
to the formation of the follicle pool from which follicles are recruited
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during reproductive life.21 In mice, Rspo1 expression becomes
signiﬁcantly downregulated in the ﬁrst week post partum,22
suggesting that RSPO1 is not required for the recruitment and
maturation of follicles, and consequently proper ovarian functioning.
From the onset of puberty, the ovary undergoes successive cycles
of follicular recruitment, maturation, OSE exfoliation, subsequent
ovulation and corpus luteum (CL) formation.23 Progesterone
synthetized by the CL is necessary to prepare the uterine wall for
implantation. LGR5-positive OSE cells are presumed to contribute
to both post-ovulatory repair of the OSE24 and, together with
LGR4-positive lutein cells, progesterone production.25,26 Activation
of canonical WNT signaling must therefore be tightly controlled
in the adult ovary. Consequently premature activation of canonical
WNT signaling in differentiating granulosa cells leads to the
appearance of precancerous follicle-like lesions around 6 weeks
post partum, and 57% of these become granulosa cell tumors (GCTs)
before the age of 7.5 months.27
In women, ovarian cancers derive from three major histotypes:
surface epithelia, sex-chord stromal cells and germ cells.28
Approximately 3% of ovarian cancers are derived from germ
cells, 7% come from sex-chord stromal cells and 90% arise from
OSE or fallopian tube epithelium.28 GCTs are categorized into two
distinct subtypes, the juvenile and the adult form.29 Although less
common than OSE-derived cancers in women, GCT frequently occurs
in primates and domestic animals.28 Moreover, in mouse models
adult granulosa cells originate from two distinct waves of migration
of progenitor cells of the OSE.18 Given that (i) ectopic activation
of canonical WNT signaling within the ovary has oncogenic effects,27
(ii) RSPO1 is an activator of canonical WNT signaling during ovarian
development14 and (iii) RSPO1 is ampliﬁed in ovarian cancers,3 we
hypothesized that RSPO1 misexpression could be a cause of ovarian
defects and eventually cancer development. Using a gain-of-function
mouse model (Sf1:CreTg/+; R26Rspo1/+), we show that post partum
maintenance of Rspo1 expression in somatic cells of the mouse ovary
impairs homeostasis of the healthy ovary.
RESULTS
Rspo1 expression is downregulated in adult follicles
RSPO1/Rspo1 is highly expressed in somatic cells of the ovary
during embryogenesis.6,30 In the 2 weeks following birth, however,
Rspo1 expression is downregulated as evidenced by qRT–PCR
analysis.22 To obtain a more detailed expression proﬁle and
identify the cell types that express Rspo1 late in development and
during the postnatal period, we performed in situ hybridization
experiments. Strong expression of Rspo1 was found within the
fetal ovary at 16.5 days post coitum (dpc), which signiﬁcantly
decreased after birth and remained at low levels in granulosa cells
of cortical follicles in adult ovaries (Figures 1a–c). In contrast, Rspo1
was robustly expressed in the OSE at all stages (Figures 1a–c). To
understand whether RSPO1 was able to activate canonical WNT
signaling, we next analyzed whether the Axin2+/LacZ reporter of
this pathway31 was expressed in the adult ovary. β-Galactosidase
staining was detected in the OSE and in the ovarian stroma as well
as in oocytes (Figures 1e–g). By contrast, granulosa cells were
weakly stained after birth, indicating that RSPO1/WNT signaling is
downregulated in this compartment of the follicle.
Increased RSPO1 expression activates canonical WNT signaling
in adult ovaries
To assess the importance of Rspo1 repression in the postnatal ovary,
we next investigated the effect of induced Rspo1 expression on
ovarian homeostasis. To this end, we generated Sf1-CreTg/+; R26Rspo1/+
mice (Supplementary Figure S1). We ﬁrst established the ability of
female Sf1-CreTg/+; R26Rspo1/+ mice to ectopically express Rspo1
throughout the ovary (Figures 1c and d). Next, we assessed that
induced expression of Rspo1 led to a strong, although variable,
follicular activation of canonical WNT signaling by detecting
β-galactosidase in ovaries from Sf1-CreTg/+; R26Rspo1/+; Axin2+/LacZ
mice (Figures 1g and h). This conﬁrmed that sustained expression


















Figure 1. Pattern of Rspo1 expression and activation of WNT signaling in ovaries. Expression of Rspo1 revealed by in situ hybridization in
R26Rspo1/+mouse ovaries at 16.5 dpc (a), 4 dpp (b) and 12 months (c). Rspo1 is expressed at low level in the R26Rspo1/+mouse adult ovary, mainly
in the epithelial surface and in granulosa cells of some follicles in the ovarian cortex, whereas adult Sf1-CreTg/+; R26Rspo1/+ovaries display Rspo1
expression throughout the whole organ (d). Activation of the canonical WNT signaling by RSPO1 visualized by β-galactosidase staining of
ovaries expressing the Axin2-LacZ reporter. Axin2-LacZ is expressed at 2.5 and 12 months in pre-antral follicles and the stroma (e and g) and
strongly expressed in oocytes and the epithelial surface surrounding the ovary (e and f, arrow) in R26Rspo1/+mice. Induced Rspo1 expression
leads to Axin2-LacZ expression in the whole Sf1-CreTg/+; R26Rspo1/+ovary (h) with strong staining in granulosa cells (arrow) and weaker staining
in aberrant follicular structures lesions (*). Scale bars: 300 μm.
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Rspo1 activation induces ovarian defects, subfertility and cancer
To evaluate the effect of RSPO1 expression on ovarian function we
ﬁrst assessed the fertility of Sf1-CreTg/+; R26Rspo1/+ female mice.
Litter sizes were signiﬁcantly reduced with only 1.25 pup/female
(±1.58) compared with 7.25 pups/female (±1.16) for R26Rspo1/+
littermates (n= 8 plugged female per genotype). By the age of
6 months double-transgenic mice were all sterile (n= 8). Macro-
scopic observation of dissected ovaries revealed a marked
increase in the size of mutant ovaries when compared with those
of the control littermates (Figures 2a–c). The size of the transgenic
ovaries increased over time (data not shown).
To gain insides into the ovarian phenotype, we examined 170
haematoxylin and eosin-stained slides containing serial sections from
14 murine ovaries from Sf1-CreTg/+; R26Rspo1/+ mice. Histological
analysis revealed a variety of abnormalities, ranging from 100%
penetrance of dense follicle-like lesions to tumors in about 10% of
ovaries (Figure 2). The ovarian tissue presented multifocal aggregates
of neoplastic cells that arrange either in discrete solid aggregates,
solid sheets or in microfollicular pattern (Figures 2f–h) reminiscent to
granulosa cells. They are bland, ovoid, have distinct borders, scant
amount of cytoplasm and ovoid nuclei. On the basis of these
observations, we conclude that GCTs accumulate in Sf1-CreTg/+;
R26Rspo1/+ mouse ovaries. None of these abnormalities were detected
in control ovaries (Figure 2d). A proportion of these follicle-like
structures developed into blood-ﬁlled cysts (Figures 2i and j)
surrounded by cuboidal cells (Figure 2j) that were never observed
in ovaries from control animals. In addition, fewer corpora lutea (CLs)
were observed which is in agreement with the reduced fertility of
the Sf1-CreTg/+; R26Rspo1/+ females (Figure 2e). A proportion of
regressing CLs contained erythrocytes inﬁltration (Figures 2l and
m). One-year-old animals carried bigger cysts (Figures 2k and n),
which, in some cases, contained layered keratinocytes in the cavity
(Figure 2n). In addition to the accumulation of GCT, solid tumors
were observed in 12–18-month-old females with 1 tumor/13 Sf1-
CreTg/+; R26Rspo1/+ and 3/19 Sf1-CreTg/+; R26Rspo1/Rspo1 females,
whereas 0/22 control littermates were scored (Figure 2c). The
severity of the different defects varied between animals and was
not linked to whether they were heterozygous or homozygous for
the Rosa26-Rspo1 transgene.
We next analyzed whether GCTs were proliferative or under-
going apoptosis in 40 days post partum (dpp) Sf1-CreTg/+; R26Rspo1/+
ovaries using immunostaining for MKI67 and active CASP3,
respectively, two markers of these processes. Only occasionally, we
observed a cell expressing one of these markers in the GCT,
implying that cell proliferation and apoptosis were negligible in
these structures (Supplementary Figures S2A–D). Interestingly,
increased proliferation was detected in the stromal compartment
of Sf1-CreTg/+; R26Rspo1/+ ovaries (Supplementary Figures S2A and B).
Consistent with this proliferative activity and clear staining for the
theca cell marker SF1 (Supplementary Figures S2E and F), the theca
cell layer seems to be expanded in size as indicated by SF1 staining
(Supplementary Figure S2F).
We conclude that Rspo1 acts as an oncogene in the ovary
because its upregulation leads to ovarian tumor development.
Ovarian defects induced by RSPO1 expression occur from the
onset of puberty
We next examined the development of the ovarian phenotype in
Sf1-CreTg/+; R26Rspo1/+ mice before and soon after pubertal age.
Immunostaining revealed that follicle-like structures are composed
of FOXL2-positive granulosa cells (Figures 3e and f) indicating they
are indeed aberrant follicles. To investigate when these abnormal
follicular structures ﬁrst appear, we analyzed histological sections
at different stages. Pre-pubertal ovaries (21 dpp) appeared normal
and no follicular lesions were detected (Figures 5a and b). The ﬁrst
phenotypic changes became apparent in 28 dpp ovaries (n= 6;
Figures 3a and b). At this age most of the follicles contained an
oocyte. By 40 dpp, serial histological sections analysis revealed an
increased abundance of aberrant follicular structures with the
majority of follicles being devoid of oocytes (Figures 3c and d). To
further investigate the status of the aberrant follicles, we stained
sections of ovaries from 40 dpp mice for AMH (anti-Müllerian
hormone), a speciﬁc marker of early granulosa cells in primary to
early antral follicles.32 AMH-positive follicles were observed at this
stage in Sf1-CreTg/+; R26Rspo1/+ mice, however, the abnormal follicular
structures were negative for this marker (Figures 3g and h).
Vimentin (VIM), a marker for mural granulosa cells of antral
follicles, was expressed in both R26Rspo1/+and Sf1-CreTg/+; R26Rspo1/+
ovaries (Figures 3i and j) and was also readily detectable in
aberrant follicles (Figure 3j). Thus, GCT in Sf1-CreTg/+; R26Rspo1/+
ovaries originate from maturing antral follicles and appear around
the onset of puberty, suggesting that their formation is sensitive
to gonadotrophins, two speciﬁcations of adult GCT.29
RSPO1 expression impairs ovulation leading to the formation
of GCT
As the Sf1-Cre transgene is also expressed in the pituitary that
produces multiple hormones and especially growth hormone, we
examined Sf1-CreTg/+; R26Rspo1/+ pups. Female and male mice were
healthy and their body size was normal (n= 6; data not shown),
indicating that activating Rspo1 mutations do not hamper the
development and functions of this organ. We next investigated
serum levels of gonadotropins, estradiol and progesterone in adult
Sf1-CreTg/+; R26Rspo1/+ females (Figure 4a). Luteinizing Hormone (LH)
and progesterone levels were considerably lower in Sf1-CreTg/+;
R26Rspo1/+ mice, compared with R26Rspo1/+females. This observation
was consistent with the low level of LH receptors observed in
the ovaries (Figures 4c and e) and the lack of corpora lutea
(Figure 2e). In contrast, follicle-stimulating hormone (FSH) levels
were three times higher in Sf1-CreTg/+; R26Rspo1/+ mice (Figure 4a).
In laboratory mouse strains, puberty occurs between 30–40 dpp.33
Although GCT accumulation arises at the onset of puberty, we
hypothesized that gonadotropins are involved in GCT formation in
Sf1-CreTg/+; R26Rspo1/+ ovaries. Thus, we stimulated follicular matura-
tion by injecting PMSG to pre-pubertal females (21–24 dpp). Forty-
eight hours after PMSG administration, numerous large antral follicles
in both Sf1-CreTg/+; R26Rspo1/+ and R26Rspo1/+ ovaries were observed
(Figures 5c and d), whereas they were absent in the untreated
females (Figures 5a and b). This indicates that RSPO1 does not impair
follicular growth upon FSH stimulation. However, most of these large
antral follicles in Sf1-CreTg/+; R26Rspo1/+mice exhibited structural
abnormalities ranging from asymmetric repartition of granulosa cells
to naked or abnormal oocytes (Figures 5c–g) as described in ref. 34.
In order to test whether the antral follicles present in PMSG-
treated pre-pubertal Sf1-CreTg/+; R26Rspo1/+ females are competent
for ovulation, superovulations were induced by injecting human
chorionic gonadotropin (hCG) 48 h after PMSG administration.
Ovulation takes place about 12 h post-hCG injection. We ﬁrst
examined the expression of Fshr and Foxo1, two factors involved
in follicular development, 4 h after LH/hCG injection and found
no signiﬁcant differences between the two genotypes (Figure 6a).
Twenty hours after hCG injection, control ovaries were mainly
constituted by post-ovulatory CLs, but none or only a few
were identiﬁed in Sf1-CreTg/+; R26Rspo1/+ females (Figures 6b and c).
Strikingly, in Sf1-CreTg/+; R26Rspo1/+ ovaries, follicular lesions began
to emerge and many large antral follicles were still apparent, some
of which still contained oocytes (Figure 6c), suggesting that
ovulation did not process efﬁciently. To conﬁrm this observation,
we quantiﬁed ovulated oocytes in superovulated females. Indeed,
the number of ovulated oocytes was signiﬁcantly reduced in
Sf1-CreTg/+; R26Rspo1/+ females (Figure 6d) and when ovulated, the
oocytes were devoid of a cumulus oophorus (data not shown).
Moreover, we observed a dramatic reduction of the level of
expression of Amphiregulin (Areg) and Epiregulin (Ereg), two EGF-like
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Figure 2. Ovarian defects and tumors in Sf1-CreTg/+; R26Rspo1/+ovaries. Macroscopic view of 18-month-old R26Rspo1/+ (a) and Sf1-CreTg/+; R26Rspo1/+ovaries
(b and c). The size of the Sf1-CreTg/+; R26Rspo1/+ovaries is increased in comparison with the control ovary owing to the presence of prominent tumor
tissue (c) and/or blood-ﬁlled cysts (b). Magniﬁcation 10× . Histological sections (haematoxylin and eosin staining) analysis of 12-month-old ovaries.
Sf1-CreTg/+; R26Rspo1/+ovaries (e) contain numerous multifocal aggregates of neoplastic cells that arrange either in discrete solid aggregates (*) or in
microfollicular pattern (arrows) in comparison with R26Rspo1/+ovaries (d). Scale bars, 500 μm. Magniﬁcations of structural abnormalities in
Sf1-CreTg/+; R26Rspo1/+ovaries (f–n): neoplastic cells arranged in microfollicular or rosette-like pattern (f; *) with central pale eosinophilic globule (Call–
Exner body; f and g arrow); neoplastic cells arranged in solid sheets composed of bland, ovoid, scant amount of cytoplasm and ovoid nuclei
granulosa cells. (h, arrow): hematocysts (i and j), with columnar cells (j, arrow), CL or regressing CL with erythrocytes inﬁltration (l and m, arrow),
Ovarian epithelial cyst composed of cystic and papillary structures lined with tall columnar ciliated epithelium. (k, arrow) and ovarian epithelial
inclusion cyst composed of keratinized squamous epithelium (n, arrow). Scale bars: 100 μm. a, antral follicle; cl, corpus luteum.
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Figure 3. RSPO1 promotes GCT. Histological analysis (haematoxylin and eosin staining) of R26Rspo1/+ and Sf1-CreTg/+; R26Rspo1/+ ovaries at 28 dpp
(a and b) and 40 dpp (c and d). Follicle-like structures (*) consisting of nests of disorganized, pleiomorphic granulosa cells become evident at
28 dpp (b) in Sf1-CreTg/+; R26Rspo1/+ ovaries, whereas they are not observed in R26Rspo1/+ovaries (a). They enclose oocytes at 28 dpp (b), whereas
they lack an antrum and contain no visible or a degenerating oocyte at 40 dpp (d). Scale bar: 300 μm. Immunolabelling of FOXL2 (e and f),
AMH (g and h) and Vimentin (VIM) (i and j) in R26Rspo1/+ (left panel) and Sf1-CreTg/+; R26Rspo1/+ ovaries (right panel) at 40 dpp. FOXL2 staining in
the GCT (f; *) conﬁrms the presence of granulosa cells in these follicle-like structures in R26Rspo1/+ovaries (e). The absence of AMH staining (h)
and the presence of VIM staining (j) in GCT (*) suggest that follicular maturation can occur up to the antral stages. Nuclei are labeled with DAPI
(blue). Scale bars: 100 μm. a, antral follicle; pa, pre-antral follicle, cl, corpus luteum.
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factors involved in cumulus cell-oocyte complex expansion and thus
required for ovulation (Figure 6a), which could at least partially explain
the improper ovulation phenotype in Sf1-CreTg/+; R26Rspo1/+ females.
The lack of CLs in Sf1-CreTg/+; R26Rspo1/+ ovaries (Figure 6c) suggests
that RSPO1 expression impairs the terminal differentiation of antral
follicles. Indeed, the expression of Lhr, Cyp11a1 and Star, key genes of
luteinization process of the granulosa cells which occurs upon LH/
hCG surge, was signiﬁcantly downregulated in Sf1-CreTg/+; R26Rspo1/+
(Figure 6a). As a result, although R26Rspo1/+ ovaries were ﬁlled with CLs
expressing CYP11A1, only few CYP11A1-positive CL were observed in
Sf1-CreTg/+; R26Rspo1/+ ovaries (Figures 6f and g). Interestingly, the
newly formed follicular lesions were devoid of CYP11A1 (Figure 6g). In
addition, 21–24 dpp superovulated Sf1-CreTg/+; R26Rspo1/+ ovaries
contained aberrant follicles including degenerating oocytes as
observed in 40 dpp non-superovulated Sf1-CreTg/+; R26Rspo1/+ ovaries
(Figures 3d and 6e), suggesting that follicular lesions become
apparent in the later stages of follicular development.
Altogether our results demonstrate that follicular abnormalities
observed in Sf1-CreTg/+; R26Rspo1/+ ovaries are driven by puberty,
that Sf1-CreTg/+; R26Rspo1/+ ovaries are unable to properly respond
to LH and that GCT formation is linked to FSH stimulation. These
results show that superovulation experiments induce and
accelerate the formation of GCT and that Rspo1 downregulation
within adult ovary is required for the proper occurrence of the
ovulation process and the subsequent formation of CLs.
Induced expression of RSPO1 promotes cell junction adherence
and epithelial traits in GCT
Next, we searched for an explanation for the persistence of these
abnormal follicular structures. RSPO1 is typically associated with
canonical WNT signaling as corroborated by the expression of the
Axin2+/LacZreporter31 (Figures 1g and h). However, CTNNB1 is also a
component of adherens junctions, where it associates with
cadherins (CDH).8,35 Maintaining adherence junctions has been
shown previously to inhibit apoptosis of granulosa cells thus
preventing follicular degeneration.36 Therefore, the presence of
adherens junctions was investigated in ovaries of 6-month-old Sf1-
CreTg/+; R26Rspo1/+ and R26Rspo1/+ mice by immunostainings using
the markers CTNNB1 and cell-adhesion molecule N-cadherin (CDH2).
CTNNB1 wasmostly detected at themembrane of granulosa cells of pre-
antral follicles and in granulosa cells surrounding the antrum in larger
antral follicles in control ovaries (Figures 7a and c). CTNNB1 was enriched
at the membrane of the cells in the GCT in Sf1-CreTg/+; R26Rspo1/+ ovaries











































Figure 4. Induced Rspo1 expression impairs LH-mediated luteinization. (a) Serum levels of FSH, LH, estradiol and progesterone in R26Rspo1/+
(black bars) and Sf1-CreTg/+; R26Rspo1/+ ovaries (white bars) from adult females (n=5 for each genotype). Bars represent mean± s.e.m. with
signiﬁcance set at Po0.05 (*). Expression of LH receptor revealed by in situ hybridization in adult (P40) R26Rspo1/+and Sf1-CreTg/+; R26Rspo1/+ovaries
(b–e). Lhr is strongly expressed in mural granulosa cells of mature antral (a) follicles (b and d) and in the theca cells of R26Rspo1/+ovaries, whereas
Lhr expression is clearly downregulated in antral follicles (c and e) of Sf1-CreTg/+; R26Rspo1/+ ovaries and is absent from GCT (*). Scale bars: 100 μm.
ns, not signiﬁcant.
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(Figures 7b and d). The presence of CDH2 was evident at all stages
during maturation in both genotypes (Supplementary Figures S3A, B).
GCT also strongly expressed membrane-bound plakoglobin (JUP), a
component of desmosomes and intermediate junctions (Figures 7e
and f), and the epithelial markers KRT18 and pan-cytokeratin
(Figures 7g and h and Supplementary Figures S3C–F) that are absent
or weakly expressed in follicles in control ovaries. These data reveal the
presence of strong intercellular junctions in GCT in Sf1-CreTg/+; R26Rspo1/+
ovaries, indicating that induced expression of Rspo1 increases
cellular adhesion, which in turn may promote epithelialisation of
granulosa cells and the persistence of the follicular remnants.
DISCUSSION
Although RSPO1 is crucial for ovarian development,14 here we show
that its postnatal downregulation is critical for the maintenance of
a healthy adult ovary. When RSPO1 expression is maintained, GCT
appear at the onset of puberty in 100% of the cases. Prolonged
RSPO1 expression allows follicular maturation until the late antral
stage. Most follicles are capable of responding to FSH stimulation
as previously reported for induced CTNNB1 expression,37 and fail
to respond to LH. It has been shown that FSH increases the
occurrence and onset of GCT formation.38 These GCT are classiﬁed
as adult GCT.29 Accordingly, we observed high FSH levels that could
contribute to the adult GCT formation in Sf1-CreTg/+; R26Rspo1/+ mice.
Endocrine functionality of CL involves LGR receptors.25,26 However,
neither Rspo1 nor the CTNNB1 target Axin2 is expressed in these
structures, which suggests that LGRs may act through an RSPO1/
CTNNB1 independent pathway in this cell type. In contrast, RSPO1,
stabilized CTNNB1 and LGR5 are expressed in the OSE stem cells that
contribute to post-ovulatory repair,24 putting forward that these
factors act together in the ovulation process. However, the ovulatory
defects observed in our model prevented us from analyzing whether

































Figure 5. Sf1-CreTg/+; R26Rspo1/+ ovaries respond to hormonal stimulation. Histological analysis (haematoxylin and eosin staining) of R26Rspo1/+
(a, c and e) and Sf1-CreTg/+; R26Rspo1/+ (b, d, f and g) ovaries of 21 dpp (a and b) and at 21–24 dpp stimulated by PMSG injection and collected
48 h later (c–g). When stimulated by PMSG, ovaries from both genotypes contain large antral (a) follicles (c and d) but in Sf1-CreTg/+; R26Rspo1/+
mice, most of these follicles exhibit dissymmetric mural granulosa (f and g, arrowheads) when compared with follicles of R26Rspo1/+ ovaries (e).
Aberrant follicles are also observed containing naked (*) or degenerating (**) oocytes (g). Scale bar: 300 μm (a–d) and 100 μm (e–g).
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Figure 6. Induced Rspo1 expression prevents ovulation. Quantitative RT–PCR analysis of Fshr, Foxo1, Areg, Ereg, Lhr, Cyp11a1 and Star
expression in R26Rspo1/+ (black bars) and Sf1-CreTg/+; R26Rspo1/+ ovaries (white bars) from 21–24 dpp superovulated mice, using Sdha1 as the
normalization control (a). Bars represent mean± s.e.m. (n=6 for each genotype) with signiﬁcance set at Po0.05 (*), Po0.01 (**) and Po0.001 (***).
Histological analysis (haematoxylin and eosin staining) of R26Rspo1/+ and Sf1-CreTg/+; R26Rspo1/+ ovaries at 21–24 dpp stimulated by hCG (b, c and e).
R26Rspo1/+ ovaries (b) contain many corpora lutea (cl) which are rarely observed in Sf1-CreTg/+; R26Rspo1/+ ovaries (c). Instead, these ovaries display
several GCT (*) and naked oocytes (arrowhead) in antral (indicated as a) follicles (c) and degenerating follicles (arrowhead) (e). Superovulation
experiments show a reduced number of ovulated oocytes (d) with an average of 8 and 0.6 oocyte/ovary (n=8–10) in R26Rspo1/+ and Sf1-CreTg/+;
R26Rspo1/+ females, respectively. CYP11A1 revealed by immunostaining is highly expressed in CL of R26Rspo1/+ ovaries (f) but absent in the abnormal
follicles (*) of Sf1-CreTg/+; R26Rspo1/+ ovaries (g). Nuclei are labeled with DAPI (blue). Scale bars: 100 μm.
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In addition to the granulosa cell phenotype, we observed an
enriched population of SF1-positive theca cells suggesting a role
of CTNNB1 signaling in differentiation of steroidogenic lineages.
The steroidogenic precursors of adrenal and gonadal cells have a
common origin39 and both arise from a pool of WT1-positive
cells.40,41 In adrenals, CTNNB1 is required for the formation and
maintenance of the steroidogenic cells of the adrenal cortex,42,43
but the role of this signaling pathway in the fate of the theca cells
has not been investigated to date.
Ablation of Rspo1 induces a precocious differentiation of
granulosa cells during fetal development.20 This demonstrates
that Rspo1 is required to maintain an undifferentiated state of the
granulosa cell progenitors during early development, before
Rspo1 expression decreases within the ovary around birth. Here,
we show that when Rspo1 expression is maintained, it alters the
differentiation of granulosa cells via their epithelialization. First,
CTNNB1 and JUP are maintained at the plasma membrane of
aberrant follicular structures and contribute to cell junction
formation. Although follicular atresia is promoted by oocytes
disruption,34 the maintenance of intercellular junctions can
prevent degeneration of the granulosa cells.35 This suggests that
stabilization of cell–cell contacts promote survival of the GCT
in Sf1-CreTg/+; R26Rspo1/+mice. Interestingly, in a granulosa cell
dominant-stable CTNNB1 mutant mouse model, GCTs develop via
a mechanism that mainly implies canonical WNT signaling.44 Here,
we show that RSPO1 activation in adult ovaries induces formation
of GCTs by regulating not only canonical WNT signaling activation

























Figure 7. RSPO1 expression maintains intercellular junctions and epithelial identity in GCT. Immunostaining for CTNNB1 (a–d), JUP (e and f),
and KRT18 (g and h) in 6-month-old R26Rspo1/+ (left panel) and Sf1-CreTg/+; R26Rspo1/+ (right panel) ovaries. Membrane staining for CTNNB1 and
JUP underline cellular junctions in these follicle-like structures (h). Nuclei are labeled with DAPI (blue). Scale bars: 100 μm.
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Second, GCT exhibit not only granulosa cell identity as
highlighted by FOXL2 and Vimentin expression, but also epithelial
cell traits are reactivated as shown by the concomitant expression
of epithelial markers like pan-cytokeratin and KRT18. Granulosa
cells originate from surface epithelial progenitors.45 Our results
suggest that adult granulosa cells maintain the potential to
reactivate their epithelial program if properly stimulated, and that
RSPO1 is sufﬁcient to induce this program. Moreover, FOXO1/3
and PTEN factors mutations in granulosa cells also promoted
epithelial traits reactivation in GCTs.38
The mixed identity of GCT as granulosa cells and epithelial
progenitors is likely a susceptibility factor for ovarian pathologies
including ovarian cancers. Indeed, our results evidence that after-
birth maintenance of RSPO1 expression induces GCT but also
severe ovarian pathologies and eventually cancers in mice.
In human RSPO1 has been reported as a susceptibility factor of
ovarian epithelial cancers and is ampliﬁed in 8% of them,3,4 but so
far its exact role in ovarian cancers was not clear. Here, we show
for the ﬁrst time that the overexpression of RSPO1 in mouse
ovarian tissues is sufﬁcient to lead to GCT formation with 100%
penetrance. Our results highlight RSPO1 as a main player in the
ovarian oncogenic process and provide new insights into the
molecular roles of RSPO1 in the pathology.
MATERIALS AND METHODS
Mouse strains and genotyping
The experiments were carried out in compliance with the relevant institu-
tional and French animal welfare laws, guidelines and policies and have
been approved by the French ethics committee (CIEPAL: NCE/2011-12).
Rspo1 gain-of-function model (Supplementary Figure S1) carries an
inducible Rspo1 gene knocked into the Rosa26 locus. The construct is
similar to the one reported in ref. 46 with the exception of the promoter.
Here, the Rosa26 promoter controls Rspo1 expression. R26Rspo1/+ mice were
mated with the Sf1-Crehigh (Sf1-CreTg/+) strain, which drives expression of
the Cre recombinase in somatic cells of the gonad from 11.5 dpc onward.47
Axin2-LacZ mice were described previously,31 and crossed with Sf1-CreTg/+;
R26Rspo1/+ males to generate Sf1-CreTg/+; R26Rspo1/+; Axin2+/LacZ animals.
Fertility tests were performed using 3–4-month-old Sf1-CreTg/+; R26Rspo1/+
females mated with R26Rspo1/+ males (Supplementary Figure S1). Genotyp-
ing was performed using DNA extracted from tail tips or ear biopsies of
mice. The presence of the Y chromosome and the Axin2-LacZ transgene
was determined as described previously.14
Histological analysis
Ovaries were dissected, ﬁxed in Bouin’s solution overnight, and embedded in
parafﬁn. Five-micrometer-thick sections were stained with hematoxylin and
eosin. To determine the ovarian phenotype in Rspo1 expressing ovaries,
consecutive sections were analyzed. Pictures were taken with an Axioscope 2
(Zeiss, Oberkochen, Germany) or MZ9.5 (Leica, Mannheim, Germany)
microscope coupled with an Axiocam MRc5 (Zeiss) or DHC490 (Leica)
camera and Axiovision 4.8 (Zeiss) or application suite V3.3.0 (Leica) software,
and processed with Adobe Photoshop (San Jose, CA, USA).
Serum collection and hormone assays
Blood was collected from adult mice in the same stage of estrous cycle
and allowed to clot for 90 min at room temperature. Samples were then
centrifuged and the serum was collected and stored at − 20 °C. Hormone
analyses were performed by the Ligand Assay and Analysis Core Laboratory
at The Center for Research and Reproduction, University of Virginia
(Charlottesville, VA, USA). LH, FSH, estradiol and progesterone measurements
were run in duplicates using speciﬁc assays (n= 5 for each genotype).
Superovulations
Immature 3–4-week-old mice were injected intraperitoneally (i.p.) with 5 IU/
mouse pregnant mare serum gonadotropin (PMSG) (Sigma-Aldrich, St Louis,
MO, USA) to promote follicle maturation, followed by 5 IU/mouse hCG
(Sigma-Aldrich) 48 h later to induce ovulation. Mice were humanely killed
48 h after the ﬁrst hormone injection for follicle maturation studies or 4 h
and 20 h after the second injection for ovulation and luteinization studies.
Ovaries, including fat pad, oviduct and partial uterine tube, were ﬁxed in 4%
paraformaldehyde or Bouin’s solution overnight. For qPCR analyses, ovaries
were carefully isolated from the genital tract and quickly frozen in liquid
nitrogen. For oocyte counting, immature females (n= 8 (R26Rspo1/+) and 10
(Sf1-CreTg/+; R26Rspo1/+) ovaries) were similarly superovulated and killed 20 h
after the hCG injection. Oviducts were isolated from ovary and uterus and
opened to collect the oocytes.
X-gal staining and immunological analyses
Tissue samples were ﬁxed in 4% paraformaldehyde overnight and then
processed for parafﬁn embedding or equilibrated in sucrose and embedded
in Cryomount (Histolab, Göteburg, Sweden) for cryosectioning. Cryostat or
microtome sections of 10 μm and 5 μm thickness respectively were
processed for X-Gal and immunostaining. Samples for X-Gal staining were
processed as described previously.14
Immunohistochemical experiments were performed as described in.14 The
following dilutions of primary antibodies were used: AMH (C-20, cat sc6886,
Santa Cruz Biotechnology, Dallas, TX, USA) 1:200, CTNNB1 (cat 610153, BD
Biosciences, San Jose, CA, USA) 1:250, active CASP3 (cat AF835, R&D Systems)
1:200, CDH2 (cat 33-3900, Invitrogen) 1:200, CYP11A148 1:300, FOXL221 1:400,
JUP (cat 610254, BD Biosciences) 1:250, KRT18 (cat ab52948, Abcam,
Cambridge, UK) 1:300, LHR (LHR-29, ATCC-CRL-2685, ATCC) 1:150, MKi67
(clone SP6, cat 9106, Thermo Fisher Scientiﬁc, Waltham, MA, USA) 1:200, SF1
(kindly provided by Professor Morohashi) 1:1000 and Vimentin (cat ab92547,
Abcam) 1:200. Slides were counterstained with DAPI diluted in the mounting
medium at 10 μg/ml (Vectashield, Vector laboratories, Burlingame, CA, USA)
to detect nuclei. Imaging was performed with a motorized Axio ImagerZ1
microscope (Zeiss) coupled with an Axiocam Mrm camera (Zeiss) and
processed with Axiovision LE (Zeiss) and Adobe Photoshop.
In situ hybridization
Tissue samples were ﬁxed in 4% paraformaldehyde in 1×PBS overnight at
4 °C. Seven-micrometer sections were cut for in situ hybridization experiments
using Rspo1 and Lhr digoxigenin-labeled riboprobes as described
previously.14 Each experiment was repeated on at least two gonads. Post-
hybridization washes were done in 100 mM maleic acid Ph7.5, 150 mM NaCl,
0.1% (v/v) tween-20 (MABT). Imaging was performed on a MZ9.5 microscope
(Leica) as described above and processed with Adobe Photoshop.
Quantitative PCR analysis
Individual ovaries from either adult or 21–24 dpp superovulated mice were
dissected in 1 × PBS and quickly frozen in liquid nitrogen. RNA was
extracted using the RNeasy Qiagen kit and reverse transcribed using the
RNA RT–PCR kit (Stratagene). Primers and probes were designed by Roche
Assay Design Center (http://qpcr.probeﬁnder.com/organism.jsp). Primer
sequences are available upon request to the authors. All real-time PCR
assays were carried out using LightCycler Taqman Master kit (Roche, Basel,
Switzerland). QPCR was performed on cDNA from one gonad and
compared with a standard curve. Relative expression levels of each gene
was determined in the same run and normalized on the levels of
endogenous Sdha1 cDNA. QPCR were repeated at least twice. For adult
mice, n= 4 (R26Rspo1/+) and 8 (Sf1-CreTg/+; R26Rspo1/+) gonads. For 21–24 dpp
superovulated mice, n= 6 gonads for each genotype.
Statistical analysis
Data are shown as mean± s.e.m.
All the data were analyzed by unpaired one-sided Student’s t-test using
Microsoft Excel (Redmond, WA, USA). Asterisks highlight the pertinent
comparisons and indicate levels of signiﬁcance: *Po0.05, **Po0.01 and
***Po0.001.
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